UNC13A is a modifier of survival in amyotrophic lateral sclerosis

Neurobiology of Aging

Volumn 33, Issue 3, 2012, Pages 630.e3-630.e8

  Diekstra, Frank P ^a   van Vught, Paul W J ^a   van Rheenen, Wouter ^a   Koppers, Max ^a   Pasterkamp, R Jeroen ^a   van Es, Michael A ^a   Schelhaas, Helenius J ^b   de Visser, Marianne ^c   Robberecht, Wim ^d,e   Van Damme, Philip ^d,e   Andersen, Peter M ^f   van den Berg, Leonard H ^a   Veldink, Jan H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^f UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyotrophic lateral sclerosis (ALS); Rs12608932; Survival; UNC13A

Indexed keywords

GLUTAMIC ACID;

ADOLESCENT; ADULT; AGED; ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SPECIFIC SURVIVAL; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MODIFIER GENE; NETHERLANDS; NEUROTRANSMITTER RELEASE; ONSET AGE; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PUBLICATION; SINGLE NUCLEOTIDE POLYMORPHISM; UNC13A GENE;

EID: 84855795589     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.10.029     Document Type: Article

References (25)

1. Al-Chalabi A., Fang F., Hanby M.F., Leigh P.N., Shaw C.E., Ye W., Rijsdijk F. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry 2010, 81:1324-1326.
2. Augustin I., Rosenmund C., Südhof T.C., Brose N. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature 1999, 400:457-461.
3. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci 1994, 124(suppl):96-107. 10.1016/0022-510X(94)90191-0.
4. Cheung Y.K., Gordon P.H., Levin B. Selecting promising ALS therapies in clinical trials. Neurology 2006, 67:1748-1751.
5. Chiò A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G., Consortium E. Prognostic factors in ALS: a critical review. Amyotroph. Lateral Scler 2009, 10:310-323.
6. Chiò A., Schymick J.C., Restagno G., Scholz S.W., Lombardo F., Lai S.-L., Mora G., Fung H.-C., Britton A., Arepalli S., Gibbs J.R., Nalls M., Berger S., Kwee L.C., Oddone E.Z., Ding J., Crews C., Rafferty I., Washecka N., Hernandez D., Ferrucci L., Bandinelli S., Guralnik J., Macciardi F., Torri F., Lupoli S., Chanock S.J., Thomas G., Hunter D.J., Gieger C., Wichmann H.E., Calvo A., Mutani R., Battistini S., Giannini F., Caponnetto C., Mancardi G.L., La Bella V., Valentino F., Monsurrò M.R., Tedeschi G., Marinou K., Sabatelli M., Conte A., Mandrioli J., Sola P., Salvi F., Bartolomei I., Siciliano G., Carlesi C., Orrell R.W., Talbot K., Simmons Z., Connor J., Pioro E.P., Dunkley T., Stephan D.A., Kasperaviciute D., Fisher E.M., Jabonka S., Sendtner M., Beck M., Bruijn L., Rothstein J., Schmidt S., Singleton A., Hardy J., Traynor B.J. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet 2009, 18:1524-1532.
7. Daoud H., Belzil V., Desjarlais A., Camu W., Dion P.A., Rouleau G.A. Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis. Arch. Neurol 2010, 67:516-517.
8. Dunckley T., Huentelman M.J., Craig D.W., Pearson J.V., Szelinger S., Joshipura K., Halperin R.F., Stamper C., Jensen K.R., Letizia D., Hesterlee S.E., Pestronk A., Levine T., Bertorini T., Graves M.C., Mozaffar T., Jackson C.E., Bosch P., McVey A., Dick A., Barohn R., Lomen-Hoerth C., Rosenfeld J., O'Connor D.T., Zhang K., Crook R., Ryberg H., Hutton M., Katz J., Simpson E.P., Mitsumoto H., Bowser R., Miller R.G., Appel S.H., Stephan D.A. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J. Med 2007, 357:775-788.
9. Huisman M.H.B., de Jong S.W., van Doormaal P.T.C., Weinreich S.S., Schelhaas H.J., Van Der Kooi A.J., de Visser M., Veldink J.H., van den Berg L.H. Population-based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J. Neurol. Neurosurg. Psychiatry 2011, 82:1165-1170.
10. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I.W. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24:2938-2939.
11. Laaksovirta H., Peuralinna T., Schymick J.C., Scholz S.W., Lai S.-L., Myllykangas L., Sulkava R., Jansson L., Hernandez D.G., Gibbs J.R., Nalls M.A., Heckerman D., Tienari P.J., Traynor B.J. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 2010, 9:978-985. 10.1016/S1474-4422(10)70184-8.
12. Landers J.E., Melki J., Meininger V., Glass J.D., van den Berg L.H., van Es M.A., Sapp P.C., van Vught P.W.J., McKenna-Yasek D.M., Blauw H.M., Cho T.-J., Polak M., Shi L., Wills A.-M., Broom W.J., Ticozzi N., Silani V., Ozoguz A., Rodriguez-Leyva I., Veldink J.H., Ivinson A.J., Saris C.G.J., Hosler B.A., Barnes-Nessa A., Couture N., Wokke J.H.J., Kwiatkowski T.J., Ophoff R.A., Cronin S., Hardiman O., Diekstra F.P., Leigh P.N., Shaw C.E., Simpson C.L., Hansen V.K., Powell J.F., Corcia P., Salachas F., Heath S., Galan P., Georges F., Horvitz H.R., Lathrop M., Purcell S., Al-Chalabi A., Brown R.H. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9004-9009.
13. Miller R.G., Mitchell J.D., Lyon M., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev 2007, (1). CD001447.
14. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., Maller J., Sklar P., de Bakker P.I.W., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 2007, 81:559-575.
15. Rothstein J.D. Excitotoxicity hypothesis. Neurology 1996, 47(suppl 2):S19-S26.
16. Schymick J.C., Scholz S.W., Fung H.-C., Britton A., Arepalli S., Gibbs J.R., Lombardo F., Matarin M., Kasperaviciute D., Hernandez D.G., Crews C., Bruijn L., Rothstein J., Mora G., Restagno G., Chiò A., Singleton A., Hardy J., Traynor B.J. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2007, 6:322-328. 10.1016/S1474-4422(07)70037-6.
17. Shatunov A., Mok K., Newhouse S., Weale M.E., Smith B., Vance C., Johnson L., Veldink J.H., van Es M.A., van den Berg L.H., Robberecht W., Van Damme P., Hardiman O., Farmer A.E., Lewis C.M., Butler A.W., Abel O., Andersen P.M., Fogh I., Silani V., Chiò A., Traynor B.J., Melki J., Meininger V., Landers J.E., McGuffin P., Glass J.D., Pall H., Leigh P.N., Hardy J., Brown R.H., Powell J.F., Orrell R.W., Morrison K.E., Shaw P.J., Shaw C.E., Al-Chalabi A. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 2010, 9:986-994. 10.1016/S1474-4422(10)70197-6.
18. Sorenson E.J., Mandrekar J., Crum B., Stevens J.C. Effect of referral bias on assessing survival in ALS. Neurology 2007, 68:600-602.
19. Traynor B.J., Nalls M., Lai S.-L., Gibbs R.J., Schymick J.C., Arepalli S., Hernandez D., van der Brug M.P., Johnson J.O., Dillman A., Cookson M., Moglia C., Calvo A., Restagno G., Mora G., Chiò A. Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12335-12338.
20. van Es M.A., Van Vught P.W., Blauw H.M., Franke L., Saris C.G., Andersen P.M., Van Den Bosch L., de Jong S.W., van't Slot R., Birve A., Lemmens R., de Jong V., Baas F., Schelhaas H.J., Sleegers K., Van Broeckhoven C., Wokke J.H.J., Wijmenga C., Robberecht W., Veldink J.H., Ophoff R.A., van den Berg L.H. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol 2007, 6:869-877. 10.1016/S1474-4422(07)70222-3.
21. van Es M.A., van Vught P.W.J., Blauw H.M., Franke L., Saris C.G.J., Van Den Bosch L., de Jong S.W., de Jong V., Baas F., van't Slot R., Lemmens R., Schelhaas H.J., Birve A., Sleegers K., Van Broeckhoven C., Schymick J.C., Traynor B.J., Wokke J.H.J., Wijmenga C., Robberecht W., Andersen P.M., Veldink J.H., Ophoff R.A., van den Berg L.H. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet 2008, 40:29-31.
22. van Es M.A., Veldink J.H., Saris C.G.J., Blauw H.M., van Vught P.W.J., Birve A., Lemmens R., Schelhaas H.J., Groen E.J.N., Huisman M.H.B., Van Der Kooi A.J., de Visser M., Dahlberg C., Estrada K., Rivadeneira F., Hofman A., Zwarts M.J., van Doormaal P.T.C., Rujescu D., Strengman E., Giegling I., Muglia P., Tomik B., Slowik A., Uitterlinden A.G., Hendrich C., Waibel S., Meyer T., Ludolph A.C., Glass J.D., Purcell S., Cichon S., Nöthen M.M., Wichmann H.-E., Schreiber S., Vermeulen S.H.H.M., Kiemeney L.A., Wokke J.H.J., Cronin S., McLaughlin R.L., Hardiman O., Fumoto K., Pasterkamp R.J., Meininger V., Melki J., Leigh P.N., Shaw C.E., Landers J.E., Al-Chalabi A., Brown R.H., Robberecht W., Andersen P.M., Ophoff R.A., van den Berg L.H. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet 2009, 41:1083-1087.
23. Varoqueaux F., Sons M.S., Plomp J.J., Brose N. Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse. Mol. Cell. Biol 2005, 25:5973-5984.
24. Wigginton J.E., Cutler D.J., Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet 2005, 76:887-893.
25. Zikich D., Mezer A., Varoqueaux F., Sheinin A., Junge H.J., Nachliel E., Melamed R., Brose N., Gutman M., Ashery U. Vesicle priming and recruitment by ubMunc13-2 are differentially regulated by calcium and calmodulin. J. Neurosci 2008, 28:1949-1960.